慢性心力衰竭的老年患者的治疗惯性:一种定性研究
Mengfan Jiao1,2, Wei Wang1, Chunxu Chen1
1Department of Cardiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, People's Republic of China.
Patient preference and adherence
|December 15, 2025
概括
慢性心力衰竭 (CHF) 患者治疗惯性源于中国老年人的能力,动机和机会有限. 干预措施应促进健康素养和支持系统,以改善对基于证据的治疗的坚持.
科学领域:
- 老年学是一门学科.
- 心脏病学 心脏病学
- 健康心理学 心理健康心理学
背景情况:
- 慢性心力衰竭 (CHF) 的治疗惯性是最佳患者结果的重要障碍.
- 导致惰性的患者层面因素,特别是在老年人群中,尚未得到充分研究,特别是在中国等各种医疗保健环境中.
- 了解这些因素对于制定有效的治疗策略对于患有慢性心血管疾病的老年人群至关重要.
研究的目的:
- 探索患有心血管衰竭的中国老年患者患者患者水平的治疗惯性.
- 用COM-B框架确定影响治疗惯性的行为和上下文决定因素.
- 为制定文化定制的干预措施提供信息,以解决治疗惯性问题.
主要方法:
- 使用了一种描述性的现象学设计.
- 与14名住院的老年CHF患者 (≥60岁) 进行了半结构面试.
- 在数据分析中使用了Colaizzi的七步方法,并遵守了COREQ的指导方针.
主要成果:
- 确定了三个新兴主题:能力不足 (健康素养低,症状感知不佳),动机减弱 (外部压力,不信任,缺乏激励) 和机会受限 (家庭支持不足,医疗资源有限).
- 这些因素相互作用,产生患者层面的治疗惯性.
- 具体障碍包括不充分的症状识别,低健康素养,竞争性的生活压力和有限的支持机会.
结论:
- 在老年CHF患者中,患者层面的治疗惯性是一个由认知,动机和系统限制驱动的多因素问题.
- 干预措施应侧重于提高健康素养和心理社会动机.
- 建立强大的家庭和社区支持系统对于减轻惯性和改善慢性心力衰竭管理中的患者结果至关重要.
相关概念视频
01:22Heart Failure VI: Adjunct Therapies
235
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
235
01:30Heart Failure VII: Nursing Interventions
396
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
396
01:30Heart Failure V: Medical Management
198
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
198
01:30Heart Failure IV: Classification and Diagnostic Evaluation
293
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
293
01:29Cardiomyopathy V: Interprofessional Care
313
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
313
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
879
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
879